Gastroenterology - Drug Trials For Money

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Conditions: Advanced Malignancies; Metastatic Cancer
Interventions: Drug: INCAGN01876; Drug: Nivolumab; Drug: Ipilimumab
Sponsor: Incyte Biosciences International Sàrl
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 1, 2019ClinicalTrials.govComments OffGastroenterologyClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine

Conditions: Recurrent Lung Non-Small Cell Carcinoma; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8
Interventions: Drug: Docetaxel; Drug: Gemcitabine; Drug: Gemcitabine Hydrochloride; Biological: Pembrolizumab; Drug: Pemetrexed; Drug: Pemetrexed Disodium; Biological: Ramucirumab
Sponsors: Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Condition: Influenza
Interventions: Drug: Baloxavir Marboxil; Drug: Placebo
Sponsor: Hoffmann-La Roche
Not yet recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Condition: Ulcerative Colitis
Interventions: Drug: Etrasimod; Drug: Placebo
Sponsor: Arena Pharmaceuticals
Recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Conditions: Gastro Intestinal Bleeding; Hematemesis; Melena
Intervention: Device: Video Capsule Endoscopy
Sponsors: David Cave; Olympus Corporation of the Americas
Not yet recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Condition: Malignant Neoplasm
Interventions: Drug: Dexamethasone; Other: Placebo; Other: Questionnaire; Other: Quality-of-Life Assessment; Drug: Everolimus
Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI)
Recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Condition: Ulcerative Colitis
Interventions: Drug: BMS-986165; Drug: Placebo
Sponsor: Bristol-Myers Squibb
Recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Condition: Adenomatous Polyp of Colon
Intervention: Device: Double balloon accessory device
Sponsor: Lumendi, LLC
Recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Condition: Crohn’s Disease
Interventions: Drug: Mirikizumab; Drug: Ustekinumab; Drug: Placebo
Sponsor: Eli Lilly and Company
Not yet recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

Condition: Irritable Bowel Syndrome With Diarrhea (IBS-D)
Interventions: Drug: MD-7246; Drug: Placebo
Sponsors: Ironwood Pharmaceuticals, Inc.; Allergan Sales, LLC
Not yet recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days